Description of Treatment Strategies and Patient Outcomes for Hospitalized Patients With Lyme Carditis

Courtney A Montepara1,2, Alexandra L Gordon1,3, Jude M Gdula1,2

  • 1Duquesne University School of Pharmacy, Pittsburgh, PA, USA.

Insights

Treatment for Lyme carditis showed low readmission rates across different antibiotic regimens. This study offers insights into expected outcomes and management for hospitalized patients with this Lyme disease complication.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Clinical Research

Background:

  • Lyme carditis is a serious cardiovascular complication of early disseminated Lyme disease.
  • Current treatment guidelines for Lyme carditis lack extensive supporting data.
  • Understanding treatment strategies and outcomes is crucial for effective patient management.

Purpose of the Study:

  • To describe treatment strategies and outcomes for hospitalized patients diagnosed with Lyme carditis.
  • To evaluate the effectiveness of different antibiotic regimens in managing Lyme carditis.
  • To provide data on key clinical outcomes including readmission, length of stay, and mortality.

Main Methods:

  • Retrospective descriptive study of adults admitted with Lyme carditis within a large hospital network.
  • Electronic health records were reviewed to gather data on treatment and outcomes.
  • Key outcomes included 30-day readmission, antibiotic duration, length of stay, cardiac pacing, heart block severity, PR interval changes, and mortality.

Main Results:

  • Sixty-two patients were analyzed, with most receiving ceftriaxone alone or followed by doxycycline.
  • Over 90% experienced heart block, with a significant portion requiring temporary or permanent pacemakers.
  • Low 30-day readmission rates (4.8%) and no observed mortality were reported.

Conclusions:

  • Antibiotic regimens for hospitalized Lyme carditis patients were associated with low 30-day readmission rates.
  • This study provides valuable data on outcomes and management timelines for Lyme carditis.
  • Findings support current treatment approaches and inform clinical decision-making for this condition.
Abstract

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...